Načítá se...

Deciding oral drugs after metformin in type 2 diabetes: An evidence-based approach

The most commonly used oral drug in treating type 2 diabetes (T2DM) after metformin are sufonylureas (SUs) based on the confidence gained over the several decades and because of its cheaper cost. Unfortunately, SUs are associated with secondary failure and sometimes associated with therapy related s...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Singh, Awadhesh Kumar
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171882/
https://ncbi.nlm.nih.gov/pubmed/25285276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.139214
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!